The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s induced pluripotent stem cell (iPSC) market report forecasts the induced pluripotent stem cell (iPSC) market size to grow to $4.36 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Induced Pluripotent Stem Cell (iPSC) Market Report 2023 – https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-global-market-report

Induced Pluripotent Stem Cell (iPSC) Market Size Forecast
The global induced pluripotent stem cell (iPSC) market is expected to grow from $2.69 billion in 2022 to $2.97 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global induced pluripotent stem cell (iPSC) market size is expected to grow to $4.36 billion in 2027 at a CAGR of 10.1%.

North America held the largest induced pluripotent stem cell (iPSC) market share.

Key Induced Pluripotent Stem Cell (iPSC) Market Driver ­– Increase In The Prevalence Of Chronic Disorders
According to the report published by Partnership to Fight Chronic Disorder (PFCD), it was found that out of 133 million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is driving the demand for induced pluripotent stem cell treatment.

Request for A Sample Of The Global Induced Pluripotent Stem Cell (iPSC) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

Key Induced Pluripotent Stem Cell (iPSC) Market Trend – Strategic Partnerships And Collaborations
Companies in the Induced Pluripotent stem cell market are looking for opportunities for strategic partnerships and collaborations that will help these companies to enter into new geographies and to expand product portfolios. For example, in January 2022, Bristol Myers Squibb and Century Therapeutics entered into a strategic collaboration to develop iPSC-derived allogenic cell therapies for the treatment of acute myeloid leukemia and multiple myeloma. Furthermore, in May 2022, Evotec and Sernova announced strategic partnership to develop iPSC-based beta cell replacement therapy for treatment for type 1 and type 2 diabetes.

Induced Pluripotent Stem Cell (iPSC) Market Segment
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Other Derived Cells
2) By Application: Academic Research, Drug Development And Discovery, Toxicity Screening, Regenerative Medicine
3) By End-User: Hospitals, Research Laboratories

Induced Pluripotent Stem Cell (iPSC) Market Major Players and Strategies
Major players in the induced pluripotent stem cell (iPSC) market are Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation (Cellular Dynamics), Takara Bio Inc., Astellas Pharma Inc., Fate Therapeutics, ViaCyte, StemCells, Japan Tissue Engineering Co. Ltd., Fate Therapeutics and Japan Tissue Engineering Co.

In August 2021, catalant, a Us-based pharmaceutical company, acquired RheinCell Therapeutics GmbHfor an undisclosed amount. The acquisition will help Catalent to grow in the cell and gene therapy vertical and develop therapies based on induced pluripotent stem cells. RheinCell Therapeutics GmbH is a Germany-based developer of human induced pluripotent stem cells (iPSCs) for next generation cell therapies.

The Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023 covers regional data on induced pluripotent stem cell (iPSC) market size, induced pluripotent stem cell (iPSC) market trends and drivers, opportunities, strategies, and induced pluripotent stem cell (iPSC) market competitor analysis. The countries covered in the induced pluripotent stem cell (iPSC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes, and neurons.

View More Reports Related To The Induced Pluripotent Stem Cell (iPSC) Market –
Stem Cell Global Market Report 2023
Cell Therapy Technologies Global Market Report 2023
Stem Cell Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: